Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Altea Therapeutics
Altea Therapeutics Announces Senior R&D Management Appointments to Align Product Development with Needs of Commercialization Partners
May 22nd, 2009
Altea Therapeutics, a leader in advanced transdermal drug delivery systems, announced senior R&D appointments to strengthen its product development and commercialization capabilities and to align technical operations with the needs of its alliance partners, including Amylin Pharmaceuticals Inc., Eli Lilly and Company, and Hospira, Inc. Harold Shlevin, Ph.D., joins the Company as Vice President, Operations and Commercial Development, responsible for commercial product scale-up and manufacturing. Dr. Shlevin brings to Altea Therapeutics a broad range of technical and managerial experience from research and development to commercial operations, including leadership of...
Source: Health Business Week (2009-05-22)
|
